A detailed history of Aigen Investment Management, LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 11,753 shares of FLGT stock, worth $189,693. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,753
Holding current value
$189,693
% of portfolio
0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$16.71 - $22.68 $196,392 - $266,558
11,753 New
11,753 $217,000
Q3 2023

Nov 13, 2023

BUY
$26.74 - $40.81 $239,884 - $366,106
8,971 New
8,971 $239,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $488M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.